Peroxisomal participation in psychosine-mediated toxicity: Implications for Krabbe's disease

Journal of Neuroscience Research

Volumn 80, Issue 6, 2005, Pages 845-854

  Khan, Mushfiquddin ^a   Haq, Ehtishamul ^a   Giri, Shailendra ^a   Singh, Inderjit ^a   Singh, Avtar K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Krabbe's disease; Oligodendrocytes; Peroxisomes; Plasmalogen; Psychosine; Redox

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; FREE RADICAL; GLUTATHIONE; PLASMALOGEN; PROTEIN ALKYL DIHYDROXYACETONE PHOSPHATE SYNTHASE; PSYCHOSINE; SYNTHETASE; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CELL FUNCTION; CONTROLLED STUDY; FATTY ACID OXIDATION; GLIA CELL; GLOBOID CELL LEUKODYSTROPHY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; BRAIN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FATTY ACIDS; GLUTATHIONE; LEUKODYSTROPHY, GLOBOID CELL; MICE; MICE, NEUROLOGIC MUTANTS; NEUROGLIA; PEROXISOMES; PLASMALOGENS; PSYCHOSINE; RATS; REACTIVE OXYGEN SPECIES;

EID: 21844461354     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20529     Document Type: Article

References (58)

1. Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq PE, Fahimi HD, Baes M. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159:1477-1494.
2. Beier K, Volkl A, Fahimi HD. 1992. Suppression of peroxisomal lipid beta-oxidation enzymes of TNF-alpha. FEBS Lett 310:273-276.
3. Bhattacharya S. 1998. Mechanisms of signal transduction in the stress response of hepatocytes. Int Rev Cytol 184:109-156.
4. Contreras MA, Khan M, Smith BT, Cimini AM, Gilg AG, Orak J, Singh I, Singh AK. 2000. Endotoxin induces structure-function alterations of rat liver peroxisomes: Kupffer cells released factors as possible modulators. Hepatology 31:446-455.
5. Cooper CE, Markus M, Seetulsingh SP, Wrigglesworth JM. 1993. Kinetics of inhibition of purified and mitochondrial cytochrome c oxidase by psychosine (beta-galactosylsphingosine). Biochem J 290(Pt 1): 139-144.
6. Dacremont G, Vincent G. 1995. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J Inherit Metab Dis 18(Suppl 1):84-89.
7. Dansen TB, Wirtz KW. 2001. The peroxisome in oxidative stress. IUBMB Life 51:223-230.
8. Das AK, Hajra AK. 1988. High incorporation of dietary 1-O-heptadecyl glycerol into tissue plasmalogens of young rats. FEBS Lett 227:187-190.
9. Dhaunsi GS, Singh I, Hanevold CD. 1993. Peroxisomal participation in the cellular response to the oxidative stress of endotoxin. Mol Cell Biochem 126:25-35.
10. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
11. Esch SW, Williams TD, Biswas S, Chakrabarty A, Levine SM. 2003. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach. Cell Mol Biol (Noisy-le-grand) 49:779-787.
12. Fonnum F, Lock EA. 2004. The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: exemplified with toxic effects on cerebellar granule cells. J Neurochem 88:513-531.
13. Hajra AK. 1995. Glycerolipid biosynthesis in peroxisomes (microbodies). Prog Lipid Res 34:343-364.
14. Haq E, Giri S, Singh I, Singh AK. 2003. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem 86:1428-1440.
15. Horrocks LA. 1973. Composition and metabolism of myelin phosphoglycerides during maturation and aging. Prog Brain Res 40:383-395.
16. Igisu H, Hamasaki N, Ito A, Ou W. 1988. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. Lipids 23:345-348.
17. Ilieva HS, Nagano I, Murakami T, Shiote M, Manabe Y, Abe K. 2003. Age-related changes in peroxisomal membrane protein 70 and superoxide dismutase 1 in transgenic G93A mice. Neurol Res 25:423-426.
18. Itoh M, Hayashi M, Fujioka Y, Nagashima K, Morimatsu Y, Matsuyama H. 2002. Immunohistological study of globoid cell leukodystrophy. Brain Dev 24:284-290.
19. Iwai K, Kondo T, Watanabe M, Yabu T, Kitano T, Taguchi Y, Umehara H, Takahashi A, Uchiyama T, Okazaki T. 2003. Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis. J Biol Chem 278:9813-9822.
20. Jatana M, Giri S, Singh AK. 2002. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci Lett 330:183-187.
21. Kawada Y, Khan M, Sharma AK, Ratnayake DB, Dobashi K, Asayama K, Moser HW, Contreras MA, Singh I. 2004. Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients. Mol Genet Metab 83: 297-305.
22. Khan M, Pahan K, Singh AK, Singh I. 1998. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem 71:78-87.
23. Khan M, Contreras M, Singh I. 2000. Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J Endotoxin Res 6:41-50.
24. Lazo O, Contreras M, Hashmi M, Stanley W, Irazu C, Singh I. 1988. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci U S A 85:7647-7651.
25. Lepage G, Roy CC. 1986. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120.
26. LeVine SM, Brown DC. 1997. IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 73:47-56.
27. Lopez-Huertas E, Charlton WL, Johnson B, Graham IA, Baker A. 2000. Stress induces peroxisome biogenesis genes. EMBO J 19:6770-6777.
28. Mates JM, Sanchez-Jimenez F. 1999. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4:D339-345.
29. Moser HW. 1999. The peroxisome: structure, function and biogenesis. Rev Neurol 28(Suppl 1):S37-39.
30. Moser HW, Bergin A, Cornblath D. 1991. Peroxisomal disorders. Biochem Cell Biol 69:463-474.
31. Nagan N, Zoeller RA. 2001. Plasmalogens: biosynthesis and functions. Prog Lipid Res 40:199-229.
32. Orellana BM, Guajardo V, Araya J, Thieleman L, Rodrigo R. 2001. Oxidative stress, microsomal and peroxisomal fatty acid oxidation in the liver of rats treated with acetone. Comp Biochem Physiol C Toxicol Pharmacol 128:503-509.
33. Poulos A. 1995. Very long chain fatty acids in higher animals-a review. Lipids 30:1-14.
34. Rapport MM. 1984. The discovery of plasmalogen structure. J Lipid Res 25:1522-1527.
35. Rapport MM. 1998. Reflections on the great plasmalogen puzzle: effector mediated signal transduction coupled to glyceride structures. Neurochem Res 23:273-275.
36. Recalcati S, Tacchini L, Alberghini A, Conte D, Cairo G. 2003. Oxidative stress-mediated down-regulation of rat hydroxyacid oxidase 1, a liver-specific peroxisomal enzyme. Hepatology 38:1159-1166.
37. Saito M, Iimori Y, Kamoshita S, Yanagisawa M, Sakakihara Y. 1995. Effects of peroxisomal beta-oxidation antagonist on 2′,3′-cyclic-nucleotide 3′-phosphohydrolase, membrane lipid compositions, and membrane fluidity in C-6 glial cells. Biochim Biophys Acta 1235:178-182.
38. Sakai N, Inui K, Tatsumi N, Fukushima H, Nishigaki T, Taniike M, Nishimoto J, Tsukamoto H, Yanagihara I, Ozono K, Okada S. 1996. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J Neurochem 66:1118-1124.
39. Schrader M, Fahimi HD. 2004. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 122:383-393.
40. Sheikh FG, Pahan K, Khan M, Barbosa E, Singh I. 1998. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci U S A 95:2961-2966.
41. Singh I. 1997. Biochemistry of peroxisomes in health and disease. Mol Cell Biochem 167:1-29.
42. Singh I. 2002. Peroxisomal fatty acid oxidation and cellular redox. Methods Enzymol 352:361-372.
43. Singh I, Lazo O, Kremser K. 1993. Purification of peroxisomes and subcellular distribution of enzyme activities for activation and oxidation of very-long-chain fatty acids in rat brain. Biochim Biophys Acta 1170: 44-52.
44. Singh I, Pahan K, Khan M, Singh AK. 1998. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273:20354-20362.
45. Singh I, Carillo O, Namboodiri A. 2000. Isolation and biochemical characterization of peroxisomes from cultured rat glial cells. Neurochem Res 25:197-203.
46. Singh I, Paintlia AS, Khan M, Stanislaus R, Paintlia MK, Haq E, Singh AK, Contreras MA. 2004. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res 1022:1-11.
47. Strasberg P. 1986. Cerebrosides and psychosine disrupt mitochondrial functions. Biochem Cell Biol 64:485-489.
48. Strasberg PM, Callahan JW. 1988. Lysosphingolipids and mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine. Biochem Cell Biol 66:1322-1332.
49. Suzuki K. 1995. The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol 5:249-258.
50. Suzuki K. 1998. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem Res 23:251-259.
51. Suzuki K. 2003. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol 18:595-603.
52. Suzuki K, Taniike M. 1995. Murine model of genetic demyelinating disease: the twitcher mouse. Microsc Res Tech 32:204-214.
53. Sztriha LS, Nork MP, Abdulrazzaq YM, al-Gazali LI, Bakalinova DB. 1997. Abnormal myelination in peroxisomal isolated dihydroxyacetone-phosphate acyltransferase deficiency. Pediatr Neurol 16:232-236.
54. Taniike M, Mohri I, Eguchi N, Irikura D, Urade Y, Okada S, Suzuki K. 1999. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J Neuropathol Exp Neurol 58:644-653.
55. Tapasi S, Padma P, Setty OH. 1998. Effect of psychosine on mitochondrial function. Indian J Biochem Biophys 35:161-165.
56. van den Bosch H, Schutgens RB, Wanders RJ, Tager JM. 1992. Biochemistry of peroxisomes. Annu Rev Biochem 61:157-197.
57. Van den Branden C, Roels F. 1985. Thioridazine: a selective inhibitor of peroxisomal beta-oxidation in vivo. FEBS Lett 187:331-333.
58. Wilson R, Sargent JR. 1993. Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients. J Neurochem 61:290-297.